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ABSTRACT The transbilayer movement and distribution of spin-labeled analogs of the steroids androstane (SLA) and
cholestane (SLC) were investigated in the human erythrocyte and in liposomes. Membranes were labeled with SLA or SLC,
and the analogs in the outer leaflet were selectively reduced at 4°C using 6-O-phenylascorbic acid. As shown previously,
6-O-phenylascorbic acid reduces rapidly nitroxides exposed on the outer leaflet, but its permeation of membranes is
comparatively slow and thus does not interfere with the assay. From the reduction kinetics, we infer that transbilayer
movement of SLA in erythrocytes is rapid at 4°C with a half-time of 4.3 min and that the probe distributes almost
symmetrically between both halves of the plasma membrane. We have no indication that a protein-mediated transport is
involved in the rapid transbilayer movement of SLA because 1) pretreatment of erythrocytes with N-ethyl maleimide affected
neither flip-flop nor transbilayer distribution of SLA and 2) flip-flop of SLA was also rapid in pure lipid membranes. The
transbilayer dynamics of SLC in erythrocyte membranes could not be resolved by our assay. Thus, the rate of SLC flip-flop
must be on the order of, or even faster than, that of probe reduction rate on the exoplasmic leaflet (half-time 0.5 min). The
results are discussed with regard to the transbilayer dynamics of cholesterol.
INTRODUCTION
The transbilayer distribution and movement of cholesterol
and of other biologically relevant steroids in membranes, in
particular of cholesterol, has been the subject of numerous
studies (for reviews see Schroeder, 1984; Schroeder and
Nemecz, 1990; Schroeder et al., 1996). Both lipid vesicles
and human red blood cells have been employed for those
studies (for reviews see Schroeder, 1984; Schroeder and
Nemecz, 1990; Schroeder et al., 1996). Although the phos-
pholipid asymmetry in red blood cells is unambiguously
established, there are conflicting results with respect to that
of cholesterol. From investigations involving freeze-frac-
ture electron microscopy, an enrichment of cholesterol on
the exoplasmic leaflet was reported by Fisher (1976). Lange
(1984), by measuring shape changes of human red blood
cells, concluded that there was a symmetrical distribution of
cholesterol between both leaflets (Blau and Bittmann,
1978).
In contrast, accessing cholesterol transbilayer distribution
by cholesterol oxidase and by exchange proteins, a prefer-
ential orientation of cholesterol to the cytoplasmic leaflet
was found by Brasaemle et al. (1988) and by Schroeder et
al. (1991). Similarly, data on the flip-flop rates of choles-
terol in the red blood cell membrane are contradictory; e.g.,
the rate of transbilayer movement of cholesterol determined
by cholesterol oxidase varied between 10 s (Lange et al.,
1981) and 50 min (Lange et al., 1977). However, it has been
suggested that enzymatic detection of transbilayer dynamics
by cholesterol oxidase perturbs the membrane and may
enhance sterol transbilayer movement (Thurnhofer et al.,
1986; Brasaemle et al., 1988; Schroeder and Nemecz,
1990). Other limitations of assays could be related to their
time resolution. If this resolution is on the order of or above
the characteristic time of transbilayer movement of the
steroid molecule (or analog), both the transbilayer distribu-
tion as well as movement cannot be determined accurately.
Fluorescent analogs of cholesterol either possessing an
intrinsic fluorophore such as dehydroergosterol (Fischer et
al., 1985; Schroeder, 1981; Schroeder and Nemecz, 1989;
Hapala et al., 1994; Schroeder et al., 1991; Mukherjee et al.,
1998) or with a covalently attached reporter group such as
an NBD moiety (Chattopadhyay and London, 1987;
Mukherjee and Chattopadhyay, 1996; Schroeder et al.,
1991; BoeszeBattaglia et al., 1996) have been used also to
examine the organization of biologically significant steroids
in membranes (for review see Schroeder and Nemecz,
1990). For example, using those analogs the transbilayer
cholesterol distribution of human erythrocytes has been
studied by two independent assays: 1) leaflet-selective flu-
orescence quenching of dehydroergosterol by the reactive
reagent trinitrobenzenesulfonic acid and 2) measurement of
lateral diffusion of NBD-labeled cholesterol by fluores-
cence photobleaching, which is different for the exo- and
cytoplasmic leaflet (Schroeder et al., 1991). Those assays
revealed an asymmetric distribution of cholesterol across
the plasma membrane with 75% of the probe present in
the cytoplasmic leaflet and a rapid flip-flop between both
leaflets even at low temperature. For dehydroergosterol a
half-time of the transbilayer migration of 6 min at 4°C
was reported (Schroeder et al., 1991). It is not known
whether such a fast transbilayer movement of cholesterol is
protein mediated. Very recently, it has been suggested that
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for macrophages the ABCG1 protein is involved in trans-
bilayer transport of cholesterol (Klucken et al., 2000).
Spin-labeled analogs of biologically relevant steroids
have been widely used also to characterize the physical
properties of steroids in membranes. It has been shown that
the spin-labeled analogs of cholestane 3-doxyl-5-choles-
tane (SLC, Fig. 1) and androstane 3-doxyl-17-hydroxy-
5-androstane (SLA, Fig. 1) adopt an orientation with the
paramagnetic NO moiety localized in the region of the
phospholipid headgroups (Morrot et al., 1987). However,
unlike fluorescent analogs, they have not been successfully
applied for studying the transbilayer distribution and move-
ment of steroids so far. A major reason for that is probably
a lack of appropriate assays.
In principal, the exposure of the NO moiety to the head-
group region should enable one to measure the transbilayer
distribution and movement of both cholesterol analogs by
leaflet specific reduction of the NO moiety into the non-
FIGURE 1 Structure of SLA, SLC, and SL-PL (respectively, of SL-PS and of SL-PC) and structure of 6-O-phenylascorbic acid.
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paramagnetic hydroxylamine, e.g., by ascorbate (Schreier-
Mucillo et al., 1976; Grover et al., 1979). However, the
accessibility of the NO moiety to ascorbic acid may be too
slow to detect rapid transbilayer movement of those analogs
(Morrot et al., 1987). Very recently, we have shown that the
reduction of NO moieties linked to phospholipids (PLs)
located in the headgroup region can be enhanced by more
than one order of magnitude when using the derivative
6-O-phenylascorbic acid (Fig. 1) (Marx et al., 1997). This
compound is less polar than ascorbic acid, which results in
a more efficient interaction with membrane associated NO-
nitroxides.
In the present study we have investigated the transbilayer
movement and distribution of both molecules, SLA and
SLC, in membranes of intact red blood cells as well as in
liposomes by rapid reduction of the NO moiety of analogs
exposed to the outer (exoplasmic) leaflet by 6-O- phenyl-
ascorbic acid.
MATERIALS AND METHODS
Materials
The spin-labeled phospholipid analogs (SL-PL) of phosphatidylserine
(PS), 1-palmitoyl-2-(4-doxylpentanoyl)-phosphatidylserine (SL-PS), and
of phosphatidylcholine (PC), 1-palmitoyl-2-(4-doxylpentanoyl)-phosphati-
dylcholine (SL-PC), respectively (Fig. 1), were synthesized according to
Fellmann et al. (1994). 6-O-phenylascorbic acid (Fig. 1) was a generous
gift of Dr. K. Wimalasena (Wichita State University, Wichita, KS). The
spin-labeled analogs 3-doxyl-17-hydroxy-5-androstane (SLA), 3-
doxyl-5-cholestane (SLC), the SH-reactive spin label maleimido-tempo,
egg phosphatidylcholine (eggPC), and all other chemicals, if not otherwise
stated, were purchased at the highest purity available from Sigma (Deisen-
hofen, Germany).
Preparation of erythrocytes
Citrate-stabilized blood samples of healthy donors were purchased from
the local blood bank (Berlin, Germany). Red blood cells were washed once
in PBS (150 mM NaCl, 5.8 mM Na2HPO4/NaH2PO4, pH 7.4) to remove
plasma and buffy coat (500  g for 10 min at 4°C). Subsequently, two
additional washes in PBS were done (2000  g for 10 min at 4°C). In the
case of SL-PS, cells before labeling with the analog were preincubated for
5 min in the presence of 5 mM diisopropyl-fluorophosphate (DFP, Aldrich,
Steinheim, Germany) at 4°C to prevent hydrolysis of the analog (Calvez et
al., 1988; Morrot et al., 1989).
If indicated, erythrocytes were preincubated for 15 min at 37°C with
N-ethyl maleimide (NEM) (2 mM). After two washes in PBS, red blood
cells were labeled with SLA as described below.
Labeling of red blood cells with SLA and SLC
Analogs were dissolved in chloroform at a final concentration of 1 mM
(stock solution), and 36 l of the stock solution was added to a glass tube
and dried under nitrogen. In the case of SLA, the analog was dissolved in
4 l of ethanol, and 300 l of PBS was added. One volume of the solution
was mixed with one volume of erythrocyte sediment. For SLC, the analog
was dissolved by addition of 100 l of -methyl-cyclodextrin (5 mM) in
PBS and subsequently mixed with 250 l of red blood cell sediment. The
analogs and red blood cells were incubated for 15 min at room temperature.
Subsequently, red blood cell suspensions were washed three times with
PBS. Red blood cells were labeled with the analogs corresponding to 0.7
mol % of endogenous lipids.
Labeling of red blood cells with SL-PC and SL-PS
and measurement of transbilayer lipid
redistribution by the back-exchange assay
SL-PC and SL-PS were incorporated into the erythrocyte plasma mem-
brane, and the amount of analog in the outer monolayer was measured
using the back-exchange method as described (Calvez et al., 1988; Morrot
et al., 1989). Briefly, suitable amounts of analog (corresponding to 1 mol
% of endogenous phospholipids) in chloroform/methanol (1:1) were dried
under nitrogen and resuspended in 1 vol of PBS. Subsequently, 2 vol of
erythrocyte suspension (final hematocrit 33%) preincubated with DFP (see
above) were mixed with the analog dispersion and incubated at the exper-
imental temperature (4°C). As deduced from stopped-flow experiments
incorporation of the analog into the outer leaflet occurred within 10 s
(Marx et al., 1997). To assess transbilayer redistribution, at regular inter-
vals, 80 l of the suspension was drawn and mixed with 25 l of ice-cold
PBS containing 10% fatty-acid-free BSA. After 1 min of incubation on ice,
the suspension was centrifuged (13,000  g for 2 min), and 50 l of the
supernatant was drawn and mixed with 5 l of 100 mM potassium
ferricyanide to reoxidize reduced lipid analogs. The amount of probe
present in the supernatant corresponding to lipid analogs in the outer leaflet
was determined from the intensity of the EPR spectrum measured at a
Bruker ECS 106 spectrometer (Bruker, Karlsruhe, Germany). Hydrolysis
of the spin-labeled analogs into lyso derivatives that would become obvi-
ous from the appearance of three narrow peaks superimposed on the
anisotropic spectrum of BSA-bound spin labels was not observed.
Preparation and labeling of liposomes
Lipids of erythrocyte plasma membrane were isolated according to the
procedure of Bligh and Dyer (1959). Total phospholipid content was
quantified by measuring the phospholipid phosphorus upon destruction of
a lipid aliquot with 70% perchloric acid for 30 min at 180°C (Rouser et al.,
1966). Cholesterol content was measured by using the Boehringer kit
(Mannheim, Germany). Lipids from erythrocyte membranes contained
phosphatidylcholine (35%), sphingomyelin (25%), phosphatidylethanol-
amine (35%), and phosphatidylserine (5%) with a molar ratio of cholesterol
to phospholipid of 0.89. Erythrocyte lipids or lipids of the desired compo-
sition dissolved in chloroform:methanol (1:1 v/v) were mixed with spin-
labeled analogs (1.5 mol %) and dried under a stream of nitrogen. Small
unilamellar vesicles (SUVs) were prepared by sonification in PBS using a
Branson sonifier W250 (Carouge-Geneve, Switzerland) at an output con-
trol setting of 2 and a duty cycle of 50% for 10 min in a glass tube cooled
in an ice bath. For preparation of large unilamellar vesicles (LUVs), the
dried lipid film containing spin-labeled analogs was hydrated by vortexing
with PBS to give a final lipid concentration of 1 mM. The resulting
aqueous phospholipid dispersion was subjected to five freeze-thaw cycles
and was then extruded 10 times through two 0.1-m polycarbonate filters
(extruder from Lipex Biomembranes, Vancouver, Canada; filters from
Costar, Nucleopore, Tu¨bingen, Germany). In the case of SL-PL, this
procedure gives liposomes with a symmetrical transbilayer distribution of
analogs. To prepare vesicles with SL-PL exclusively located on the outer
leaflet (asymmetrically labeled vesicles) liposomes were labeled after
preparation.
Reduction of spin-labeled lipids by
6-O-phenylascorbic acid
The stock solution of 6-O-phenylascorbic (100 mM in PBS) was always
prepared immediately before experiments. The pH of the stock solution
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was adjusted to a pH of 6.8. Note that 6-O-phenylascorbic is unstable at
basic pH. A 50-l volume of precooled (4°C) labeled red blood cells
(sediment) or liposome suspension was mixed with 10 l of ice-cold stock
solution of 6-O-phenylascorbic and filled into a 50-l capillary tube
(Corning, Pyrex, disposable micropipettes, Aldrich, Milwaukee, WI). Im-
mediately after sealing, the capillary was mounted in an EPR spectrometer
(ECS 106, Bruker, Karlsruhe, Germany). The temperature of the sample
was adjusted by a stream of nitrogen surrounding the capillary tube. To
follow the reduction of the NO moiety of analogs by 6-O-phenylascorbic
acid we measured the intensity of the low-field line at 4°C as a function of
time (microwave power 20 mW, modulation amplitude 4G, and magnetic
field modulation 100 kHz). We did not use the mid-field line to avoid
interference with the signal arising from 6-O-phenylascorbic. The earliest
time point could be taken 75 s after mixing labeled membranes with the
reducing substance.
MODEL
From the reduction kinetics of EPR intensity by 6-O-phe-
nylascorbic acid, the transbilayer distribution and move-
ment of steroid analogs in red blood cell membranes were
calculated by nonlinear regression. For that purpose, we
have fitted the kinetics according to the model shown in Fig.
2 (example described for SLA).
Movement of spin-labeled steroid analogs from the outer
(exoplasmic) to the inner (cytoplasmic) leaflet and vice
versa is characterized by the rate constants ki (flip) and k0
(flop). Both rate constants are assumed to be similar with
k  ki  ko. Permeation of 6-O-phenylascorbic acid across
membranes is slow with respect to k (see Results). Thus, in
the time course of the experiment spin-label reduction by
6-O-phenylascorbic acid occurs only on the outer leaflet.
The concentration of 6-O-phenylascorbic acid is in large
excess over the concentration of analogs and may therefore
be taken to be constant. Thus, the reduction process is
pseudo-first-order with respect to analogs, and the reduction
kinetics can be well described by a single exponential with
kR (kR  kR  [6-O-phenylascorbic acid]). An additional
precondition of the approach is that k  kR.
SLAo, SLAi, and SLAR are the intact androstane labels on
the outer and inner leaflet and the reduced label, respec-
tively. The differential equations and their analytical solu-
tion describing the model shown in Fig. 2 are as follows (the
same equations are valid for the cholestane label SLC):
d SLAot
dt
 k SLAit SLAot kR SLAot (1)
d SLAit
dt
 k SLAot SLAit (2)
d SLARt
dt
 kR SLAot (3)
The analytical solution is given in Marx et al. (2000).
Curves were fitted to SLAtot(t)  SLAo(t) 	 SLAi(t) where
SLAtot(t) respresents the label intensity at the time of ascor-
bate addition. Nonlinear regression was performed by using
the software package Sigma Plot 4.0 (Jandel Scientific,
Erkrath, Germany).
RESULTS
Reduction of spin-labeled phospholipids in
erythrocyte membranes by
6-O-phenylascorbic acid
Different preconditions have to be fulfilled to access the
transbilayer motion and distribution of spin-labeled lipids
in red blood cell membranes by the chemical reduction of
the NO moiety using 6-O-phenylascorbic acid. First,
permeation of 6-O-phenylascorbic acid to the cytoplas-
mic leaflet and intracellular lumen of red blood cells has
to be negligible in the time course of the assay. Second,
reduction of analogs present in the exoplasmic leaflet has
to be rapid in comparison with their transbilayer move-
ment. To verify that hypothesis, we have probed whether
those preconditions are fulfilled by using short-chain
spin-labeled phospholipid analogs (for the structure of
which see Fig. 1) because the transbilayer motion and
distribution of those analogs are well known from former
studies (Seigneuret and Devaux, 1984; Morrot et al.,
1989).
Immediately after labeling of red blood cells at 4°C,
the spin-labeled phospholipid analogs of phosphatidyl-
serine (SL-PS) and of phosphatidylcholine (SL-PC) are
exclusively located in the exoplasmic leaflet as probed by
the back-exchange assay (see also Morrot et al., 1989).
FIGURE 2 Model used for fitting the kinetics of 6-O-phenylascorbic
acid reduction of spin-labeled steroids SLA and SLC in red blood cell
(RBC) membranes. SLAo and SLAi are the amount of analogs on the outer
(exoplasmic) and inner leaflet, respectively. ki and ko are the rate constant
of the flip (inward) and flop (outward) movement, respectively. SLAR
corresponds to the analog reduced by 6-O-phenylascorbic acid. The rate
constant of reduction is kR. For details see Model and Results sections.
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All analogs in the exoplasmic leaflet were accessible to
6-O-phenylascorbic acid; the EPR intensity of both ana-
logs disappeared very rapidly after addition of this re-
ducing agent at 4°C (final concentration 17 mM; Fig. 3,
SL-PC not shown). The half-time of the reduction was
40 s. In a next set of experiments, SL-PS was allowed
to redistribute to the cytoplasmic leaflet (see Materials
and Methods). Inward redistribution of SL-PS is due to
the action of the ATP-consuming aminophospholipid
translocase (Seigneuret and Devaux, 1984; Zachowski et
al., 1986). Four hours at 4°C after labeling, 50% of
SL-PS redistributed to the cytoplasmic leaflet as assessed
by the back-exchange assay. Upon addition of 6-O-phe-
nylascorbic acid to those red blood cells, we observed a
rapid decline of the EPR intensity corresponding to re-
duction of analogs confined to the exoplasmic leaflet.
After 4 min a plateau was reached (Fig. 3).
Fitting of the data from 0 to 600 s of incubation with
6-O-phenylascorbic acid to a single exponential reveals a
plateau of 55% of analog shielded from reduction. This
value corresponds to analogs located within the cytoplasmic
leaflet and is in good agreement with the measurements
carried out by the back-exchange assay. However, upon
longer incubation in the presence of 6-O-phenylascorbic
acid, we observed a further, but slow decline of the EPR
intensity (Fig. 3). This is explained by a slow permeation of
6-O-phenylascorbic acid (see below) causing also reduction
of analogs on the cytoplasmic leaflet after longer times of
incubation. Because the passive transbilayer movement un-
der our conditions (4°C) is very slow (Seigneuret and De-
vaux, 1984) we can preclude that the reduction is due to
outward redistribution of SL-PS becoming exposed to 6-O-
phenylascorbic acid.
We investigated the permeation of 6-O-phenylascorbic
acid across the red blood cell membrane by an indepen-
dent approach. For that purpose, red blood cells were
incubated with the SH-reactive spin label maleimido-
tempo. This label is known to permeate the red blood cell
membrane and to label covalently SH groups, predomi-
nantly those of hemoglobin (Daveloose et al., 1983).
After removal of unbound label, we incubated red blood
cells with 17 mM 6-O-phenylascorbic acid and recorded
the EPR amplitude as a function of time at 4°C. Initially,
we observed a slight decrease of the EPR amplitude of
8% (Fig. 3). Very likely, this reflects reactive groups
on the membrane surface accessible to 6-O-phenylascor-
bic acid. However, subsequently, the signal remained
almost constant. Only after incubation times above 10
min was an enhanced reduction of the intensity observed,
indicating permeation of 6-O-phenylascorbic acid into
the cytoplasm of red blood cells; e.g., after 17 min,
20% of the intracellular EPR intensity disappeared. The
same results were obtained when red blood cells were
co-labeled with maleimido-tempo and SLA or SLC (data
not shown). Although the signal of both analogs vanished
rapidly upon addition of 6-O-phenylascorbic acid (see
below), we found the same behavior for the EPR signal of
maleimido-tempo as described for red blood cells that did
not contain SLA or SLC.
However, at 14°C permeation of 6-O-phenylascorbic acid
through the red blood cell membrane was rapid (curve not
shown). After 10 min of incubation with 17 mM 6-O-
phenylascorbic acid, the EPR intensity of maleimido-tempo
decreased by 30%. After 20 min less than 20% of the
original intensity remained.
In conclusion, 6-O-phenylascorbic acid is able to reduce
rapidly SL-PL localized in the exoplasmic leaflet at low
temperature (4°C). Analogs on the cytoplasmic leaflet are
efficiently shielded from the reduction process because per-
meation of 6-O-phenylascorbic acid across the red blood
cell membrane was slow at low temperature. Reduction of
spin-labeled groups present in the cytoplasmic leaflet was
negligible during the initial 10 min. Only upon longer
incubation did permeation and, thus, reduction of the latter
probes become significant.
Reduction of SLA and SLC in erythrocyte
membranes by 6-O-phenylascorbic acid
After labeling red blood cells with SLA (see Materials
and Methods) a typical membrane spectrum (not shown)
was recorded with no indication of analog clustering.
Upon addition of 6-O-phenylascorbic (final concentra-
tion 17 mM) to red blood cells labeled with SLA at 4°C,
we found an initial rapid reduction of the EPR intensity
(Fig. 4); within 75 s it declined by 50%. This was due
FIGURE 3 Reduction of EPR intensities of SL-PS and of 4-maleimido-
tempo in red blood cells by 6-O-phenylascorbic acid. Reduction was
performed in the presence of 17 mM 6-O-phenylascorbic acid at 4°C. The
intensity of the low-field EPR line was measured immediately (f) or 4 h
after labeling ( and , two independent experiments) with SL-PS
(incubation at 4°C) or after labeling red blood cells with 4-maleimido-
tempo (F) (see Materials and Methods). Kinetics of reduction of SL- PS
( and ) were fitted to a single exponential (——).
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to reduction of SLA localized on the exoplasmic leaflet at
the time of addition of 6-O-phenylascorbic acid. Subse-
quent to the rapid decline, a slower decrease of the
intensity was observed. After 10 min only 15% of the
original intensity remained. As shown above, we can
preclude significant permeation of 6-O-phenylascorbic
acid during this time interval. Therefore, we surmise that
the slower reduction reflects redistribution of SLA from
the cytoplasmic to the exoplasmic leaflet becoming ac-
cessible to 6-O-phenylascorbic acid. We note, that essen-
tially the same reduction kinetics were measured when
6-O-phenylascorbic acid was added after labeling red
blood cells with SLA for 4 h at 4°C, 25°C, or 37°C (Fig.
4, shown for 25°C and 37°C).
We have fitted the kinetics to a single exponential as well
as to the model equations described above (Fig. 2) by
nonlinear regression. Typical fits are shown in Fig. 4 (solid
line, model; dashed line, single exponential). As is obvious,
a single exponential does not fit the data at all. On the other
hand, fits according to our model lead to reasonably good
agreement with the experimental data. In Table 1 results of
fitting kinetics from four independent experiments are sum-
marized. The results strongly suggest that SLA is almost
symmetrically distributed between both membrane leaflets.
Transbilayer motion is fast with a half-time of 4.4 min. In
comparison, the half-time of SLA reduction by 6-O-pheny-
lascorbic acid on the exoplasmic leaflet is about one order
of magnitude faster (0.5 min). Reduction was much
slower when using ascorbic acid at the same concentration
(Fig. 4).
Preincubation of red blood cells with NEM did not
significantly affect the reduction of SLA by 6-O-pheny-
lascorbic (Fig. 4). We obtained essentially the same
values for the steady-state transbilayer distribution
(58.5% on the exoplasmic leaflet) and the half-times of
transbilayer motion (5.2 min) and of reduction of the NO
moiety (0.46 min) from fitting of the respective kinetics
to the model (Fig. 4, dotted line). After incubation of red
blood cells with NEM under the same conditions, the
initial rate of PS inward redistribution mediated by the
aminophospholipid translocase was reduced by a factor
of 50 (see also Morrot et al., 1989).
Because the cholestane analog SLC cannot be incorpo-
rated into red blood cell membranes by simple incubation of
cells with the spin-labeled analog, we successfully em-
ployed the analog intercalated into -methyl-cyclodextrin
(see Materials and Methods). By incubation of red blood
cells with this complex, we could incorporate SLC into the
membranes. To prevent an extraction of endogenous cho-
lesterol during the labeling procedure in the presence of
-methyl-cyclodextrin, we used a rather low concentration
of -methyl-cyclodextrin as well as a low incubation tem-
perature (5 mM for 15 min at room temperature). Controls
indicated that there were no significant changes of the
cholesterol concentration in red blood cell membranes be-
fore and after incubation with -methyl-cyclodextrin. The
amount of cholesterol was 4.4 mol/ml packed cells and 4.5
mol/ml packed cells (average of two independent mea-
surements) with and without incubation with -methyl-
cyclodextrin.
The reduction of SLC incorporated into red blood cells by
6-O-phenylascorbic acid was much faster in comparison to
FIGURE 4 Reduction of EPR intensities of SLA and SLC, respectively,
in membranes of red blood cells by 6-O-phenylascorbic or ascorbic acid.
Red blood cells were labeled with SLA without (F, f,, and) or with
preincubation of red blood cells in the presence of NEM (E). Reduction
was performed at 4°C in the presence of 17 mM ascorbic acid (f) or in the
presence of 17 mM 6-O-phenylascorbic acid immediately after labeling (F
and E) or after incubating labeled cells 4 h at 25°C () or at 37°C ().
The intensity of the low-field EPR line was measured. Data for SLA (F
and E) were fitted by nonlinear regression to the model presented in Fig.
2 (——, without NEM;   , with NEM preincubation). A single exponen-
tial does not fit well the data (— — —; shown only for the data of the
control, without NEM preincubation). (Inset) Reduction of SLC at 4°C in
the presence of 17 mM ascorbic acid (Œ) or in the presence of 17 mM
6-O-phenylascorbic acid immediately after labeling (‚) or after incubating
labeled cells 4 h at 25°C (). Typical experiments are shown.
TABLE 1 Reduction of SLA in red blood cell membranes by 6-O-phenylascorbic acid
Steady-state transbilayer distribution of SLA;
SLA on the exoplasmic leaflet (%)
Flip-flop of SLA
Reduction of SLA by
6-O-phenylascorbic acid
k (1/min) t1/2 (min) kR (1/min) t1/2
R (min)
56.6 
 5.6 0.158 
 0.011 4.37 1.260 
 0.332 0.55
The EPR intensity of SLA was recorded in the presence of 17 mM 6-O-phenylascorbic acid at 4°C (typical example is given in Fig. 4). Kinetics were fitted
to the model presented in Fig. 2 by nonlinear regression. Results of four independent measurements are presented as mean 
 SE of estimate.
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that of SLA (Fig. 4, inset). The kinetics could be well fitted
to a single exponential function. We surmise a rapid flip-
flop of SLC in red blood cell membranes with a rate
constant which is in the order of that of the reduction
process. We preclude the hypothesis that the rapid reduction
could be due to the fact that after labeling, SLC being
exclusively located in the exoplasmic leaflet redistributed
only slowly to the cytoplasmic leaflet. This conclusion is
based on our observation that the reduction kinetics did not
change when the reducing agent was added after prolonged
incubation (4°C, 25°C or 37°C, 4 h) of red blood cells
labeled with SLC (Fig. 4, inset, shown for 25°C). As for
SLA, reduction of SLC by ascorbate was much slower in
comparison to that by 6-O-phenylascorbic acid (Fig. 4,
inset).
Reduction of spin-labeled lipids in liposome
membranes by 6-O-phenylascorbic acid
We have measured the reduction of SLA and SLC by
6-O-phenylascorbic acid at 4°C in liposomes made from
erythrocyte lipids (Fig. 5). The EPR intensity vanished
completely as observed for red blood cells. As for red blood
cell membranes, reduction of SLC by 6-O-phenylascorbic
acid was much faster in comparison with that of SLA. The
size of liposomes did not affect the reduction kinetics,
because we found no difference between SUVs and LUVs
(Fig. 5). However, we did not observe a biphasic disappear-
ance of the intensity of SLA in liposomes as for red blood
cells. The data can be well fitted to a single exponential (see
solid and dashed line in Fig. 5). The half-times of intensity
decay are 2.6 min and 2.2 min for SUVs and LUVs, respec-
tively (for SLC 0.4 min). We surmise that the reduction of
SLA or SLC by 6-O-phenylascorbic acid on the outer leaflet
of liposomes is rate limiting and that the flip-flop of analogs
is on the same order or even faster. Nonlinear regression
showed that the model discussed above (Fig. 2) fits the
kinetics too. However, a critical statistical analysis revealed
that fitting was overparameterized in the latter case, the
standard error of fitted parameters being on the order of
their value or even larger.
Reduction of SLA by 6-O-phenylascorbic acid was stud-
ied in SUVs consisting of eggPC. We found that the EPR
intensity declined more rapidly than in the case of lipo-
somes made of lipids extracted from red blood cells (Figs.
5 and 6). Within 100 s the intensity of SLA in eggPC
liposomes was reduced by more than 80%. The decay of the
EPR intensity could be well fitted by a single exponential
(solid line) with a half-time of 0.58 min.
Addition of cholesterol caused a slower reduction of SLA
(Fig. 6). For vesicles with a molar ratio of eggPC:choles-
terol of 2:1, the kinetics of reduction was very similar to that
observed for liposomes of lipids extracted from erythrocytes
(Fig. 5, inset). To test whether cholesterol also affects the
reduction kinetics in membranes of erythrocyte lipids, we
prepared liposomes containing a phospholipid composition
similar to that known for the erythrocyte membrane (PC,
30%; SM, 30%; PE, 30%; PS, 10%) without and with
cholesterol (molar ratio of cholesterol to phospholipid was
0.8). Reduction of SLA by 6-O-phenylascorbic acid in those
liposomes became significantly slower in the presence of
cholesterol (Fig. 5, inset).
Notably, we did not observe for any type of liposomes a
biphasic decline of the EPR intensity upon addition of
FIGURE 5 Reduction of EPR intensities of SLA (F and E) and SLC
(‚), respectively, in liposomes of erythrocyte lipids by 6-O-phenylascorbic
acid (17 mM) at 4°C. The intensity of the low-field EPR line was mea-
sured. Liposomes were prepared in the presence of spin-labeled analogs.
Data are fitted to a single exponential (lines). F and ——, SLA, LUVs; E
and   , SLA, SUVs. (Inset) Reduction of SLA by 6-O-phenylascorbic acid
in liposomes of a phospholipid composition similar to that of the human
erythrocyte membrane (PC, 30%; SM, 30%; PE, 30%; PS, 10%): ,
without cholesterol; ƒ, with cholesterol (molar ratio of cholesterol to
phospholipid was 0.8). Data are fitted to a single exponential (lines).
FIGURE 6 Reduction of EPR intensities of SLA and SL-PC (inset),
respectively, in SUVs of eggPC by 6-O-phenylascorbic acid (17 mM) at
4°C. The intensity of the low-field EPR line was measured. f, SLA in
eggPC vesicles; ‚, SLA in eggPC:cholesterol vesicles (95:5); , SLA in
eggPC/cholesterol vesicles (2:1). (Inset) ƒ, SL-PC, symmetrically labeled
eggPC vesicles; , SL-PC asymmetrically labeled eggPC vesicles.
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6-O-phenylascorbic acid as found for red blood cells. Ki-
netics of SLA reduction in liposomes could be well de-
scribed by a single exponential.
An alternative explanation for the rapid and complete
reduction of SLA and SLC in liposomes could be the
permeation of 6-O-phenylascorbic acid across the mem-
brane causing also reduction of analogs present in the inner
leaflet. We can rule out this explanation because we have no
indication of 6-O-phenylascorbic acid permeation in the
time course of the experiment. For liposomes of erythrocyte
lipids labeled symmetrically with SL-PC, we observed
within 200 s a reduction only of those analogs localized on
the outer leaflet (not shown).
We can preclude also that 6-O-phenylascorbic acid per-
meates the lipid bilayer of eggPC liposomes. Upon addition
of 6-O-phenylascorbic acid to SUVs labeled symmetrically
with SL-PC, we observed a decrease of the EPR intensity
reaching rapidly a plateau (Fig. 6, inset). As revealed from
nonlinear regression (single exponential) the half-time of
the decrease is 0.39 min. The plateau of 40% corresponds
to the analogs in the inner leaflet. This value is in agreement
with the theoretical distribution that can be derived mathe-
matically for SUVs for which the surface area of the inner
membrane leaflet is significantly smaller than that of the
outer leaflet (Thomas and Poznansky, 1989). Remarkably,
the plateau remained almost stable in the time course of our
experiments. This confirms our previous observation (see
Marx et al., 1997) that at 4°C the permeation of 6-O-
phenylascorbic acid across the liposome membrane is neg-
ligible and that 6-O-phenylascorbic acid does not trigger a
flip-flop of lipids. Moreover, when SLA was simulta-
neously incorporated in those liposomes, we found the same
stable plateau for SL-PC (data not shown; distinct parts of
membrane spectra of SLA and of SL-PC could be well
distinguished). Thus, the presence of SLA does not perturb
the permeability properties of lipid membranes.
DISCUSSION
In the present study we have assessed the transbilayer
distribution and movement of the spin-labeled steroids SLA
and SLC in membranes of lipid vesicles and red blood cells
by the selective reduction by 6-O-phenylascorbic acid of the
nitroxides present in the exoplasmic leaflet at low temper-
ature (4°C). We found that the transbilayer movement of
SLA was rapid even at this low temperature with a half-time
of 4.3 min whereas the half-time of reduction was 0.5
min. The half-time of SLA flip-flop is very close to that
recently reported for a NBD-labeled cholesterol analog in
red blood cell membranes, 6 min at 4°C (Schroeder et al.,
1991). However, we were not able to resolve the transbi-
layer dynamics of SLC. The half-time of SLC flip-flop was
of the order or even shorter (0.5 min) than the character-
istic time of spin-labeled steroids reduction on the exoplas-
mic leaflet. Nevertheless, within the experimental time
course the reducing agent 6-O-phenylascorbic acid neither
permeates the red blood cell membrane nor triggers a trans-
bilayer redistribution of lipids by perturbing the membrane
structure. We could not measure the fast flip-flop of SLA or
of SLC by using ascorbate instead of 6-O-phenylascorbic
acid. Employing the spin-labeled analog SL-PC, we have
previously shown for red blood cell membranes that in
comparison with 6-O-phenylascorbic acid the half-time of
reduction by ascorbate is about one order of magnitude
higher, even if it is used at a fivefold higher concentration
(Marx et al., 1997). Thus, the rate of reduction of the NO
moiety by ascorbate would be on the order of or much lower
than that of the transbilayer movement of SLA and SLC,
respectively. Unfortunately, our assay does not allow us to
measure the transbilayer movement of steroid analogs at
higher or even at physiological temperatures. Both the in-
terference of permeation of 6-O-phenylascorbic acid as well
as the expected faster flip-flop of analogs at those temper-
atures limit the applicability of the approach.
SLA distributes almost symmetrically between both
halves of the plasma membrane. Data may indicate a slight
preference for the exoplasmic leaflet (57%) but do not
support a pronounced asymmetric transbilayer arrangement.
We can preclude that the assay was performed under con-
ditions that do not correspond to the steady-state transbi-
layer distribution of SLA. Due to the rapid transbilayer
movement, the analog adopts already during labeling of red
blood cells its steady-state distribution (see Materials and
Methods). Indeed, the reduction kinetics and, thus, the val-
ues of the parameters obtained from fitting were similar
when the assay was performed after prolonged incubation of
labeled red blood cells.
This almost symmetric distribution of SLA is in accor-
dance with studies on human red blood cells reporting a
symmetric distribution of cholesterol (Blau and Bittmann,
1978; Lange, 1984) but differs from the reported preferen-
tial localization of dehydroergosterol and of an NBD-la-
beled cholesterol in the cytoplasmic leaflet (Schroeder et al.,
1991). For both fluorescent cholesterol analogs, it was con-
cluded that 75% of the respective molecules are localized in
this monolayer. Support for a symmetric distribution of
cholesterol is given by our combined kinetic and thermo-
dynamic approach to simulate the transbilayer asymmetry
of the major lipids in the red blood cell membrane (Heinrich
et al., 1997). This model takes into account the lipid com-
position as well as the passive and active routes of transbi-
layer motion of lipids in red blood cell membranes experi-
mentally characterized in quantitative terms. Moreover, the
model reflects the stationary asymmetric distribution of
phospholipids under in vivo conditions provided that a rapid
transbilayer movement of cholesterol of the order of min-
utes and a symmetric steady-state distribution of cholesterol
are assumed. For a slow transbilayer movement of choles-
terol, the model does not reflect the asymmetric in vivo
transbilayer distribution of phospholipids at all.
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The contradictory observations on transbilayer distribu-
tion may arise from the fact that due to the chemical
structure the various analogs behave and distribute differ-
ently in membranes with respect to each other as well as
with respect to endogenous cholesterol. Thus it remains to
establish how those steroid spin labels and fluorophores
reflect the behavior of cholesterol. An essential feature of
cholesterol is the polar OH group, which is important for
lipid interactions and the orientation of cholesterol in mem-
branes. For membranes it is generally accepted that the OH
group of cholesterol is oriented toward the lipid headgroup
region and that the rigid steroid body penetrates deeply into
the hydrophobic region of the lipids. Both analogs used here
lack the OH group. However, the rapid reduction of the
analogs in the exoplasmic leaflet of red blood cells by
6-O-phenylascorbic acid suggests that the doxyl moiety is
localized in the lipid headgroup region and that the analog
orientation in a lipid monolayer is similar to that of choles-
terol. Indeed, it has been shown that SLC adopts only one
orientation in a monolayer where the NO moiety interacts
with the headgroup region but not with the methyl residues
of phospholipid acyl chains (Morrot et al., 1987). Obvi-
ously, the short acyl chain of cholesterol and SLC is an
important determinant of monolayer orientation. This be-
comes evident from the orientational behavior of SLA lack-
ing the short acyl chain. From the observation that the NO
moiety of SLA interacts with the headgroup region and with
the methyl residues of phospholipid acyl chains, it is has
been concluded that SLA adopts at least two orientations
within a monolayer with a reorientation rate of 107 s1
(Morrot et al., 1987). We can preclude that our assay
measures the two different orientations of SLA in a mono-
layer (Morrot et al., 1987) rather than the transbilayer dis-
tribution of the analog. In any case reorientation of SLA
must be several orders of magnitude faster than the reduc-
tion of SLA by 6-O-phenylascorbic acid in red blood cell
membranes. Moreover, from the comparison of the flip-flop
between SLC and SLA we surmise that the short acyl chain
facilitates the transbilayer movement of steroid molecules
as SLC and cholesterol.
Taken together, we conclude that due to its structure SLC
resembles more closely the orientation and transbilayer
movement of cholesterol in membranes. Of course, we are
aware that a spin-labeled cholesterol analog preserving the
typical OH group would be the best choice to characterize
endogenous cholesterol. To this end, we have used such an
analog bearing the NO moiety on the short acyl chain.
However, this analog adopts a similar stable orientation in
the membrane as cholesterol and SLC because its NO
moiety was not accessible to 6-O-phenylascorbic acid.
Upon addition of the reducing agent, the EPR intensity
declined only very slowly (data not shown). Nevertheless,
the use and comparison of the steroid analogs as SLC and
SLA provide information on structural features of choles-
terol determining its transbilayer movement.
A central question is whether membrane proteins are
involved in transbilayer movement of cholesterol (analogs).
Although we cannot preclude that an accelerated flip-flop of
analogs occurs at the interface between membrane proteins
and lipids, we have no indication that in red blood cells a
protein-mediated transport is involved in the rapid transbi-
layer movement of analogs. Pretreatment of red blood cells
with NEM affected neither the flip-flop nor the transbilayer
distribution of SLA. It is known that NEM treatment abol-
ishes the fast inward movement of phosphatidylserine me-
diated by the ATP-dependent aminophospholipid translo-
case (Morrot et al., 1989; Seigneuret and Devaux, 1984;
Zachowski et al., 1986). Likewise, the fast, rather unspecific
flip-flop of phospholipids in the endoplasmic reticulum is
NEM sensitive, indicating the presence of a flippase (Herr-
mann et al., 1990; Buton et al., 1996; Menon et al., 2000).
Moreover, if membrane proteins would be required we
would expect a significantly reduced transbilayer movement
of SLA or SLC in lipid vesicles. This was essentially not the
case. We observed a rapid reduction of the EPR intensity of
spin-labeled steroid analogs in liposomes consisting of
eggPC or a phospholipid composition similar to that of red
blood cell membranes. The kinetics of the intensity loss
could be well described by a single exponential. Thus, we
could not resolve the transbilayer distribution and move-
ment of SLA and SLC by our assay. This strongly suggests
that the reduction of the NO moiety by 6-O-phenylascorbic
acid on the outer leaflet (t1/2 of 30 s) is the rate-limiting
step rather than the transbilayer movement of the analogs.
The rate-limiting role of the NO reduction process is sus-
tained by the fact that the half-time of SL-PC reduction on
the outer leaflet is quite similar to that of SLA reduction in
liposomes, e.g., in eggPC vesicles, 0.4 min and 0.6 min,
respectively. Thus, we cannot provide a precise value of the
SLA flip-flop rate in those lipid vesicles. We can only
roughly estimate that the half-time of transbilayer move-
ment of SLA is 30 s or even less at 4°C. Reduction of the
NO moiety by 6-O-phenylascorbic acid was slower in lipo-
somes made from red blood cell lipids but still faster in
comparison with membranes of intact red blood cells. In
that case, too, reduction of analogs by 6-O-phenylascorbic
acid on the outer leaflet is rate limiting, and we could not
distinguish between reduction of analogs on the outer leaflet
and flip-flop of analogs. From the estimated rate constant of
EPR intensity decline, we can conclude that the half-times
of transbilayer movements of SLA and SLC are of the order
of 2.5 and 0.4 min, respectively, or even less at 4°C.
Regardless of the fact that we can only give an upper limit
of the half-time of analog flip-flop, the data indicate that the
analogs undergo a rapid transbilayer movement even in the
absence of proteins.
The rapid transbilayer movement of SLC and SLA is in
agreement with the recent observation of a rapid cholesterol
flip-flop in 1-stearoyl-2-oleoyl phosphatidylcholine lipo-
1426 Mu¨ller and Herrmann
Biophysical Journal 82(3) 1418–1428
somes (Leventis and Silvius, 2001). The data indicated that
the half-time of cholesterol flip-flop is 1–2 min at 37°C.
The difference in the reduction of analogs between the
various lipid vesicles implies that the lipid composition
affects the accessibility of analogs for 6-O-phenylascorbic
acid and, perhaps, their transbilayer movement. We surmise
that cholesterol may resemble an essential determinant of
analog reduction in liposomes. As shown upon incorpora-
tion of cholesterol into eggPC liposomes or liposomes con-
sisting of a phospholipid mixture similar to that of red blood
cell membranes the reduction of SLA was significantly
slower. The kinetics of reduction was quite similar to that
observed for SLA in vesicles made from erythrocyte lipid
extracts.
What could be the molecular basis for a rapid transbilayer
movement of cholesterol (analogs)? According to its struc-
ture cholesterol is a molecule predominantly of hydrophobic
nature penetrating deeply into the hydrophobic part of the
membrane. Very likely, this specific nature enables a rapid
transbilayer movement of cholesterol. Indeed, although
phospholipids are anchored to the respective leaflet of a
bilayer by their large polar headgroups preventing a rapid
flip-flop in lipid bilayers, those polar elements are missing
in cholesterol. It has been shown previously that cholesterol
exhibits a dynamic, fluctuating motion parallel to the mem-
brane normal, thereby protruding into the opposite mono-
layer of the bilayer (Gliss et al., 1999; Huster et al., 1998).
We surmise that such a motion may facilitate a rapid flip-
flop. Of course, apart from polar groups, the interaction with
neighboring lipid components as a determinant of transbi-
layer movement has to be considered as well (Leventis and
Silvius, 2001).
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